FDA Inspection 1008597 — Biomat USA, Inc. d/b/a Talecris Plasma Resources
The FDA completed an inspection of Biomat USA, Inc. d/b/a Talecris Plasma Resources on April 11, 2017 in Provo, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 11, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Provo, UT (United States)